8-K: TOMI Environmental to Merge with Carbonium Core

Sentiment:

Quarterly Results and Merger Announcement


TOMI Environmental Solutions reported Q1 2026 results and announced a non-binding letter of intent to merge with Carbonium Core, Inc. in a deal valued at $120 million.

Capital raiseThe proposed merger involves issuing TOMI common stock equal to 19.99% of outstanding shares.The deal includes a new series of preferred stock convertible into common stock.

Summary

  • Reported Q1 2026 revenue of $1.65 million, a 5% increase year-over-year.
  • Announced a non-binding letter of intent to acquire Carbonium Core, Inc., a producer of nuclear-grade graphite, at an implied enterprise valuation of $120 million.
  • Operating expenses decreased by 15% to $1.46 million compared to Q1 2025.
  • Net loss for the quarter was $811,000, or $0.04 per share.
  • Sales order backlog stands at $1.7 million, with an integration pipeline of $4.3 million.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral-to-positive development; while the core business shows operational improvement, the transformative merger introduces significant execution risk and dilution concerns.

Positives

  • Revenue grew 5% year-over-year to $1.65 million.
  • Applicator sales surged 139% year-over-year.
  • Operating expenses were reduced by 15% through disciplined cost management.
  • Net cash provided by operating activities improved by $572,000 compared to Q1 2025.
  • Integration pipeline grew to $4.3 million across 13 customers.

Negatives

  • Gross margin declined to 50% from 60% in Q1 2025 due to price discounting and product mix.
  • Service revenue decreased 41% year-over-year.
  • Net loss widened to $811,000 compared to $256,000 in the prior year period (which included a one-time $535,000 tax credit).
  • Shareholders' equity significantly declined to $550 from $588,504 at year-end 2025.

Risks

  • The proposed merger with Carbonium Core is non-binding and subject to due diligence, definitive agreements, and shareholder approval.
  • Reliance on a limited number of products for the majority of revenue.
  • Potential for failure to consummate the merger or realize expected synergies.
  • Ongoing operating losses and negative cash flow from operations excluding working capital adjustments.
  • Market competition and the need for continued regulatory approvals in international markets.

Future Outlook

The company is focused on finalizing the merger with Carbonium Core by May 30, 2026, while continuing to drive recurring revenue through BIT Solution sales, converting a $4.3 million integration pipeline, and leveraging new EU/UK regulatory approvals to expand international market share.

Management Comments

  • The first quarter of 2026 was a strong start to the year.
  • Carbonium Core brings a vertically integrated U.S. production platform for nuclear-grade graphite, a critical strategic material at the nexus of advanced nuclear energy and AI data center demand.
  • We are moving forward with focused urgency toward a definitive agreement by May 30, 2026.

Industry Context

StockSavvy.ai notes that TOMI is attempting a pivot from a pure-play decontamination firm to a diversified materials and technology company. The move into nuclear-grade graphite aligns with the current 'AI infrastructure' investment trend, though it represents a significant departure from their core disinfection business.

Comparison to Industry Standards

  • The 50% gross margin is lower than typical high-margin SaaS or specialized biotech equipment peers, reflecting the current reliance on hardware sales.
  • The $120 million valuation for Carbonium Core is significant relative to TOMI's current market capitalization, suggesting a highly dilutive transaction if finalized.
  • The company's focus on non-Chinese supply chains for graphite mirrors broader U.S. industrial policy trends (FEOC rules).

Stakeholder Impact

  • Existing shareholders face potential dilution of approximately 20% plus additional dilution from convertible preferred stock.
  • Customers may benefit from expanded product offerings if the merger succeeds.
  • Creditors will be monitoring the impact of the merger on the company's balance sheet and cash flow.

Next Steps

  • Complete due diligence on Carbonium Core.
  • Sign definitive merger agreement by May 30, 2026.
  • Seek stockholder approval for the merger and preferred stock issuance.
  • Convert $4.3 million integration pipeline into recognized revenue.

Key Dates

DateDescription
2026-01-06Installation of SteraMist Hybrid System at a research university.
2026-01-20Sale of Custom Engineered System in the UK.
2026-02-23UK regulatory authorization for BIT Solution and SteraMist iHP.
2026-03-03Strategic partnership with Total Clean Air.
2026-03-16Expansion of Canadian operations.
2026-03-18Expansion into food safety sector.
2026-03-24Engagement with Mexican dairy manufacturer.
2026-03-25Biocidal product authorization from Dutch regulatory authority.
2026-03-31End of first quarter 2026.
2026-04-30Execution of non-binding letter of intent to merge with Carbonium Core.
2026-05-08Release of Q1 2026 financial results.
2026-05-30Expected date for signing definitive merger agreements.

Recommendation

hold

The stock is in a transition phase. While the core business is showing signs of operational discipline, the proposed merger is highly speculative and dilutive. Investors should wait for the definitive agreement and further clarity on the integration of the graphite business before increasing positions.

Keywords

TOMI Environmental Solutions, Carbonium Core, SteraMist, Nuclear-grade graphite, Decontamination, Merger, TOMZ

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.